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We provide evidence regarding the nature, causes, and consequences of intelligence in patients with 21-hydroxylase deficient
congenital adrenal hyperplasia (CAH). Intelligence and quality of life (psychological adjustment) were measured on multiple
occasions from childhood to young adulthood in 104 patients with CAH (62 females, 42 males) and 88 unaﬀected relatives (31
females, 57 males). Information on disease severity (CAH type, age at diagnosis, genital virilization for girls) and salt-wasting
crises was obtained from medical records. There was no evidence of intellectual deficit in either female or male patients with CAH.
Intelligence was not significantly associated with psychological adjustment or disease characteristics. CAH itself does not appear
to increase risk for poor intellectual function. In a sample of patients with generally good disease control, intelligence is not related
to adjustment problems, disease severity, or salt-wasting crises.
1. Introduction
Controversies about the nature and causes of psychological
outcome in individuals with disorders of sex development
(DSDs) have focused on gender identity, sexuality (especially
related to surgery), and quality of life [1–3]. There has been
less attention paid to intelligence, although there has been
a concern that intellectual impairment might be associated
with adjustment problems [4]. Most of the systematic
evidence about outcome in DSDs comes from congenital
adrenal hyperplasia (CAH), the most common DSD.
Intelligence is composed of several key attributes, includ-
ing abstract thinking, reasoning, problem-solving, and abil-
ity to adapt to the environment [5]. Intelligence measured
by standard tests is important because it is associated with
a variety of psychological, social, economic, and health
outcomes [5]. A review of studies through 2000 indicated
that overall intelligence of individuals with CAH is within
the normal range, but might be lower in patients with salt-
wasting (SW) than with simple-virilizing (SV) CAH [6].
One aspect of intelligence, spatial ability, has been found
to be aﬀected by CAH, but in diﬀerent ways in the two
sexes: compared to same-sex controls, females with CAH
have higher spatial ability (probably as a result of prenatal
androgen excess) and males have lower spatial ability (for
unknown reasons) [6–8]. Data published since the review
suggest that there is a more pronounced intellectual deficit in
female patients with CAH than had been reported previously
[4]. The deficit was proposed to be caused by the disease and
its treatment (e.g., prenatal androgen excess, hyponatremia)
and to lead to lowered quality of life, but the hypothesized
causes and consequences of the deficit were not tested.
The renewed concerns about intellectual deficits in CAH
and associations with psychological adjustment [4] generate
three key questions. First, what is the nature and extent of
the deficit, and is it found in both sexes? Although most
work focuses on females with CAH, some factors proposed to
influence intelligence (e.g., hyponatremia) are also present in
males with CAH. Second, what are the causes of intellectual
deficit? This can be examined through associations between
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intelligence and disease characteristics. Third, what are
the psychological consequences of intellectual deficit? This
can be examined through associations between intelligence
and psychological adjustment. We address these questions
with data from a long-term followup of individuals with
CAH whose intelligence and psychological adjustment were
assessed on multiple occasions from childhood through
young adulthood.
2. Methods
2.1. Subjects. Participants were part of a behavioral study
of individuals with CAH secondary to 21-hydroxylase
deficiency studied on several occasions. They were ini-
tially recruited in childhood or adolescence through eight
university-aﬃliated pediatric endocrinology clinics in the
midwestern United States. Unaﬀected relatives similar in
age served as controls. Participants represented a range
of socioeconomic backgrounds, and most were Caucasian.
There were 192 participants from 90 families studied at
several points between the ages of 3 and 30 years, although
not all subjects had data at all times; there were 62 females
and 42 males with CAH, 31 unaﬀected female relatives
(29 sisters, 2 cousins) and 57 unaﬀected male relatives (54
brothers, 3 cousins). 90% of families invited to participate in
the project agreed.
Behavioral data from some participants have been
reported; for summary, see [1, 9]. In brief, females with
classical CAH are behaviorally more male-typical and less
female-typical than their unaﬀected sisters, with androgen
having large eﬀects on activity interests but minimal eﬀects
on gender identity; males with classical CAH are similar to
unaﬀected males in gender-related characteristics studied;
females and males with CAH have good psychological
adjustment.
The research was approved by Institutional Review
Boards at all institutions. Depending on age, participants
provided oral assent or written consent; parents of minors
provided written consent for their children’s participation.
2.2. Measures and Procedures. Subjects were tested between
one and four times between 1989 and 2004. At the initial
assessment (Time 1), they ranged in age from 3 to 13 years
(M = 6.9), but cognitive testing was only conducted on
those aged 7 and older (M = 9.5). Subsequent assessments
included both the initial subjects and new subjects, and
included cognitive tests for all subjects. The second assess-
ment (Time 2) occurred on average six months after the
first, and subjects were 3 to 13 years old (M = 8.10). The
third assessment (Time 3) occurred on average 4.6 years later,
and subjects were 3 to 19 years old (M = 10.33). The final
assessment (Time 4) occurred on average 5.6 years after that,
and subjects were 9 to 30 years old (M = 15.87). Most
participants were tested more than once: 33% had only one
assessment, 43% had two, 16% had three, and 8% had all
four assessments.
Intelligencewasmeasured with standardized tests. Raven’s
Progressive Matrices Test was administered at Time 1; it
correlates well with other measures of intelligence [10].
Peabody Picture Vocabulary Test [11] was administered at
Times 2 and 3. Age-appropriate multiple-choice Vocabulary
Tests [12, 13] were administered at Time 4. Vocabulary
tests were used because they correlate with measures of
intelligence [11] but are short (reducing participant burden),
and prevent inflated scores in females with CAH who
have higher spatial ability than unaﬀected females [8] and
depressed scores in males with CAH who have lower spatial
ability than unaﬀected males [6, 7].
Psychological adjustment was measured with parent-
report on all four occasions, and with self-report once or
twice in adolescence. Parents completed the Child Behavior
Checklist (ages 3–18) or the Young Adult Behavior Checklist
(age 18 and older) [14, 15]; analyses focused on Internalizing
(withdrawal, somatic complaints, depression, and anxiety),
Externalizing (aggressive and delinquent behavior), and
Total Behavior Problem scales. Adolescents completed the
Self-Image Questionnaire for Young Adolescents [16]; an
average of all nine scales was used. Some adjustment data
have been reported [17] so only associations with intelligence
are described.
Disease characteristics that might aﬀect intelligence were
rated from medical records without knowledge of behavioral
results. Data were available for approximately half the
sample; there were no significant behavioral diﬀerences
between those with versus without data. The overwhelming
majority of patients were diagnosed clinically, consistent
with the fact that most were born before newborn screen-
ing for CAH was implemented in the states in which
they lived. Most participants had good disease control, as
measured by growth rate, bone age, and concentration of
17-hydroxyprogesterone; see [18] for detailed information
about assessment and results. Measures used here include
indicators of disease severity (type of CAH, age at diagnosis,
degree of genital virilization in girls) and number of salt-
wasting crises documented in childhood; descriptive data
are shown in Table 1. Type of CAH was classified as simple
virilizing (SV-), mild salt wasting (SW-), or severe SW. SW-
CAH required elevated plasma renin activity for age and
responsiveness to mineralocorticoid therapy. Classification
as mild SW-CAH required that all measurements of serum
sodium be at least 129mmol/L, and that there be no episodes
of hypotension or shock; classification as severe SW-CAH
required that serum sodium in the neonatal period be less
than 129mmol/L, or that there be at least one episode of
hypotension or shock.
2.3. Analysis Procedure. Intelligence test scores of patients
and controls were compared using analysis of variance, with
factors of sex and status (CAH, control), and covariate
of age for tests that were not age-standardized. Separate
analyses were conducted for eachmeasure at each time point;
multivariate analyses were not used because not all subjects
had complete data. Associations between intelligence and
adjustment were assessed with correlations; scores were
adjusted so positive correlations reflect high intelligence
associated with good adjustment. We examined correlations
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Table 1: Disease characteristics of patients with CAH.
Type of CAH Females Males
Nonclassical (NC) 7 6
Simple Virilizing (SV) 6 2
Mild Salt-Wasting (Mild SW) 11 8
Severe Salt-Wasting (Severe SW) 31 24
Age at Diagnosis of CAH Females Males
<6 months 38 27
6–35 months 3 0
>36 months 12 11
Prader Stage at Diagnosis (females only) NC SV Mild SW Severe SW
0 6 2 0 0
1 1 1 2 1
2 0 1 3 3
3 0 1 1 12
4 0 1 3 11




Note. Entries are numbers of subjects. Some participants do not have complete data, so total numbers vary across characteristics.
of intelligence to adjustment at the same point in time,
and at earlier and later times, in order to assess time-
lagged consequences of intelligence for adjustment and
vice versa. Associations between intelligence and disease
characteristics were also assessed with correlations. Because
of the importance of detecting problems if they are present,
Type I error was set at .05 and there were no corrections
for multiple tests; increased Type I error with multiple
comparisons is discussed later.
3. Results
3.1. Group Comparisons on Intelligence. Data on intelligence
test scores and test ages for females and males with and
without CAH at all assessments are shown in Table 2. There
was no evidence of intellectual deficit in either females or
males with CAH at any assessment. There was one significant
eﬀect of status, reflecting higher scores of patients with CAH
than controls at Time 2 (P < .05). This eﬀect was qualified
by amarginally significant interaction between sex and status
(P < .07): higher scores of patients with CAH than controls
were specific to females. An interaction between sex and
status was also seen at Time 3 (P < .01), again reflecting the
higher scores of females, but not males, with CAH compared
to controls.
3.2. Associations between Intelligence and Adjustment. Intelli-
gence was generally not significantly associated with adjust-
ment, whether measured at the same or diﬀerent points
in time. Only a few correlations were significant, and they
were not consistently in the same direction. The median
correlation was −.02.
3.3. Associations between Intelligence and Disease Character-
istics. Intelligence was generally not significantly associated
with disease characteristics. Median correlations with intelli-
gence were as follows: type of CAH r = .12, age at diagnosis
r = −.07, Prader rating r = .01, number of salt-wasting
crises r = −.05. Because few patients had more than one
salt-wasting crisis, we compared individuals with one or
more crisis to individuals with no crises; t-tests showed no
significant group diﬀerences on any measure of intelligence.
4. Discussion
Across multiple measures and assessments, there was no
evidence that patients with CAH—female or male—had
impaired intelligence. If anything, females with CAH had
higher ability than unaﬀected female relatives. Further,
there was no evidence that intelligence was associated with
quality of life, as measured by parents’ reports of their
children’s behavior problems or patients’ reports of their
own functioning, and no evidence that intelligence was
associated with disease characteristics, including salt-wasting
crises. Published data from this sample show that the
disease was well-controlled in the majority of patients [18],
which might account for their favorable outcome; restricted
variability might also account for lack of association between
intelligence and salt-wasting crises.
These results are consistent with the bulk of the data
on intelligence in CAH from several countries and cohorts,
as seen in a review [6] and recent studies [7, 19, 20].
Patients with CAH are consistently seen to have normal
intelligence. Intelligence may be somewhat lower in patients
with SW-CAH than SV-CAH but both groups are within the
normal range and there is variability within groups [6, 21].
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Time 1, Progressive Matrices [10]: Number correct of 36
N 14 9 9 16
Mean 30.71 25.33 28.22 27.81
SD 4.80 8.32 4.12 4.68
Age at test (years)
Mean 10.68 8.85 8.95 9.21
SD 1.09 1.30 1.58 1.47
Time 2, Peabody Picture Vocabulary Test [11]: Standardized Score
N 18 13 18 19
Mean 105.33 92.15 102.56 101.79 F CAH>Unaﬀ+
SD 15.87 18.52 12.72 13.97
Age at test (years)
Mean 8.51 8.14 7.42 8.34
SD 3.33 1.54 2.66 2.49
Time 3, Peabody Picture Vocabulary Test [11]: Standardized Score
N 45 25 30 42
Mean 110.56 101.16 107.01 106.95 F CAH>Unaﬀ∗
SD 13.24 15.17 12.59 15.49
Age at test (years)
Mean 10.43 10.57 9.64 10.57
SD 4.17 4.80 3.76 3.51
Time 4, Vocabulary [12, 13] Percent correcta
N 44 18 29 31
Mean 0.72 0.62 0.61 0.71
SD 0.17 0.24 0.20 0.16
Age at test (years)
Mean 15.71 16.76 15.76 15.66
SD 4.99 4.28 5.07 3.61
aBecause of variability in participant age, several diﬀerent forms of this test were used. To increase the statistical power to detect group diﬀerences, scores
were combined into a single Vocabulary measure.
Most group diﬀerences are not significant. Significant eﬀects are noted, +P < .07, ∗P < .01.
Impairments may be associated with repeated hyponatremic
episodes. There is a greater likelihood of deficits in patients
who are not well-treated [4] than in those who are (as in the
current study), but one or two episodes in otherwise well-
treated patients do not appear to have adverse consequences
for intelligence. Intellectual deficits might also result from
other disease features, although this has not been tested. For
example, elevated ACTH with undertreatment might lead
to attention problems; overtreatment with glucocorticoids
might lead to cognitive and neural changes similar to those
seen in Cushing syndrome [22].
Our findings of enhanced ability on some tests in
females with CAH most likely reflect sampling fluctuation.
If intelligence does not diﬀer in populations of people
with versus without CAH, then sampling fluctuations in
individual studies may produce varying group diﬀerences,
including higher ability in CAH than in controls (as found
here), lower ability in CAH than in controls (as found by
[4, 23]) and, most often, no significant group diﬀerences in
ability [7, 19, 20, 24–28]. Group diﬀerences in intelligence are
less likely to be seen when patients are compared to siblings
(the best control for genetic and environmental influences on
intelligence) than to unrelated controls.
Our results showing few links between intelligence and
adjustment are consistent with findings in typical samples
[29]. Links may be found in a narrow context (e.g.,
intelligence correlated with the personality dimension of
Openness), or in selected groups (e.g., mentally ill, unusually
high or low ability), but overall, adjustment and ability are
not highly correlated.
Several issues bear consideration in interpreting the
results. First, intelligence was not assessed with full IQ tests,
such as Wechsler scales. But the tests used correlate well with
Verbal and Full Scale IQ, and are considered good indicators
of general intelligence [10, 11]. Second, conclusions about
associations between intelligence and disease characteristics
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must be tempered by the methods of assessment and
the nature of the sample: medical information was rated
retrospectively from medical records that varied in quality,
and most patients had good disease control as reported
elsewhere [18]. Although medical data were not available
for all participants, those with and without data were
similar in intelligence and adjustment. It is important to
emphasize that findings of normal intelligence in these
patients mean that there is little need for explanatory
medical data. Third, the sample is large enough to detect
moderate-to-large diﬀerences between patients with CAH
and unaﬀected relatives; small diﬀerences are unlikely to be
of clinical significance. Indeed, there was enough power to
detect a diﬀerence, but it was of an intelligence advantage
(not deficit) in females with CAH. The sample was also large
enough to detect moderate-to-large associations between
intelligence and adjustment and between intelligence and
disease characteristics. Fourth, Type I error was very high in
light of the many comparisons made. It is thus particularly
noteworthy that significant eﬀects were not found. Fifth, the
patients studied likely represent the population of patients
with CAH, given that most individuals contacted agreed to
participate; this increases confidence that most patients with
CAH are intellectually similar to their unaﬀected relatives.
Nevertheless, it is important to examine intelligence in
patients with CAH detected through newborn screening,
who best represent the population of patients with CAH.
5. Conclusions
Results of systematic assessment show that intelligence is
not impaired in females or males with CAH who generally
received good medical care beginning early in life, and that
ability is not associated with psychological adjustment. This
conclusion is strengthened by the consistency of findings
across repeated assessments with multiple measures. It seems
unlikely that CAH itself causes cognitive deficits.
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